Multiple dose levels (1, 4, 8, 12 mg) were tested in Phase 2, with the Phase 3 dose selection to be refined based on efficacy-tolerability balance
Elimination Diet This plan is suited to help uncover possible food sensitivities
This article summarises what current trial data reveal about potential long-term risks, who may be most vulnerable, and what patients and clinicians should discuss before considering this treatment
Food addiction: an examination of the diagnostic criteria for dependence
Fair reimbursement for telehealth services ensures providers can continue offering high-quality remote consultations, while standardized practices help maintain consistency and trust across different platforms
by TNG Founding Member Jennifer Dowd